<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Metabolic syndrome - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Metabolic_syndrome" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Metabolic_syndrome&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Metabolic_syndrome&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Metabolic_syndrome" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Metabolic_syndrome" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Metabolic_syndrome","wgTitle":"Metabolic syndrome","wgCurRevisionId":670782655,"wgRevisionId":670782655,"wgArticleId":54439,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 errors: dates","Pages containing cite templates with deprecated parameters","CS1 maint: Explicit use of et al.","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from February 2015","Articles with unsourced statements from May 2014","Articles with unsourced statements from May 2012","Diabetes","Endocrine diseases","Medical conditions related to obesity","Syndromes"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Metabolic_syndrome","wgRelevantArticleId":54439,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Metabolic_syndrome_X","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Obesity6.JPG/100px-Obesity6.JPG","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Metabolic_syndrome","wgWikibaseItemId":"Q657193"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Metabolic_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Metabolic syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Metabolic_syndrome_X&amp;redirect=no" title="Metabolic syndrome X">Metabolic syndrome X</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Dysmetabolic syndrome X</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Obesity6.JPG" class="image"><img alt="Obesity6.JPG" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Obesity6.JPG/230px-Obesity6.JPG" width="230" height="115" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Obesity6.JPG/345px-Obesity6.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Obesity6.JPG/460px-Obesity6.JPG 2x" data-file-width="1421" data-file-height="711" /></a>
<div>A morbidly obese male. Weight 146 kg/322 lbs, height 177 cm/5 ft 10 in. The body mass index is 46.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Endocrinology" title="Endocrinology">Endocrinology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td>E88.9</td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=277.7">277.7</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/605552">605552</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb31955.htm">31955</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/007290.htm">007290</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/metabolic-syndrome">Metabolic syndrome</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D024821">D024821</a></td>
</tr>
</table>
<p><b>Metabolic syndrome</b> is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions: abdominal (central) <a href="/wiki/Obesity" title="Obesity">obesity</a>, <a href="/wiki/Hypertension" title="Hypertension">elevated blood pressure</a>, <a href="/wiki/Hyperglycemia" title="Hyperglycemia">elevated fasting plasma glucose</a>, <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">high serum triglycerides</a>, and low <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">high-density lipoprotein</a> (HDL) levels. Metabolic syndrome increases the risk of developing <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> and <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes</a>.<sup id="cite_ref-pmid24711954_1-0" class="reference"><a href="#cite_note-pmid24711954-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-10.13140.2FRG.2.1.4502.4804_2-0" class="reference"><a href="#cite_note-10.13140.2FRG.2.1.4502.4804-2"><span>[</span>2<span>]</span></a></sup> Some studies have shown the <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> in the USA to be an estimated 34% of the adult population,<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> and the prevalence increases with age.</p>
<p>Metabolic syndrome is also known as <b>metabolic syndrome X</b>, <b>cardiometabolic syndrome</b>, <b>syndrome X</b>, <b>insulin resistance syndrome</b>, <b>Reaven's syndrome</b> (named for <a href="/wiki/Gerald_Reaven" title="Gerald Reaven">Gerald Reaven</a>), and <b>CHAOS</b> (in Australia).<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Metabolic syndrome and <a href="/wiki/Prediabetes" title="Prediabetes">prediabetes</a> appear to be the same disorder, just diagnosed by a different set of biomarkers.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Cause"><span class="tocnumber">2</span> <span class="toctext">Cause</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Stress"><span class="tocnumber">2.1</span> <span class="toctext">Stress</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Overweight"><span class="tocnumber">2.2</span> <span class="toctext">Overweight</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Sedentary_lifestyle"><span class="tocnumber">2.3</span> <span class="toctext">Sedentary lifestyle</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Aging"><span class="tocnumber">2.4</span> <span class="toctext">Aging</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Diabetes_mellitus_type_2"><span class="tocnumber">2.5</span> <span class="toctext">Diabetes mellitus type 2</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Coronary_heart_disease"><span class="tocnumber">2.6</span> <span class="toctext">Coronary heart disease</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Lipodystrophy"><span class="tocnumber">2.7</span> <span class="toctext">Lipodystrophy</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Psychiatric_illnesses"><span class="tocnumber">2.8</span> <span class="toctext">Psychiatric illnesses</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-13"><a href="#IDF"><span class="tocnumber">4.1</span> <span class="toctext">IDF</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#WHO"><span class="tocnumber">4.2</span> <span class="toctext">WHO</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#EGIR"><span class="tocnumber">4.3</span> <span class="toctext">EGIR</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#NCEP"><span class="tocnumber">4.4</span> <span class="toctext">NCEP</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#American_Heart_Association"><span class="tocnumber">4.5</span> <span class="toctext">American Heart Association</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Other"><span class="tocnumber">4.6</span> <span class="toctext">Other</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Rheumatic_diseases"><span class="tocnumber">4.7</span> <span class="toctext">Rheumatic diseases</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#Prevention"><span class="tocnumber">5</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-23"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-24"><a href="#Controversy"><span class="tocnumber">9</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1 tocsection-25"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The main sign of metabolic syndrome is <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">central obesity</a> (also known as visceral, male-pattern or apple-shaped adiposity), overweight with adipose tissue accumulation particularly around the waist and trunk.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup></p>
<p>Other signs of metabolic syndrome include <a href="/wiki/High_blood_pressure" title="High blood pressure" class="mw-redirect">high blood pressure</a>, decreased fasting serum <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">HDL</a> cholesterol, elevated fasting serum <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a> level (VLDL triglyceride), <a href="/wiki/Impaired_fasting_glucose" title="Impaired fasting glucose">impaired fasting glucose</a>, <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>, or prediabetes.</p>
<p>Associated conditions include <a href="/wiki/Hyperuricemia" title="Hyperuricemia">hyperuricemia</a>, <a href="/wiki/Fatty_liver" title="Fatty liver">fatty liver</a> (especially in concurrent <a href="/wiki/Obesity" title="Obesity">obesity</a>) progressing to <a href="/wiki/Nonalcoholic_fatty_liver_disease" title="Nonalcoholic fatty liver disease" class="mw-redirect">nonalcoholic fatty liver disease</a>, <a href="/wiki/Polycystic_ovarian_syndrome" title="Polycystic ovarian syndrome" class="mw-redirect">polycystic ovarian syndrome</a> (in women), <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a> (in men), and <a href="/wiki/Acanthosis_nigricans" title="Acanthosis nigricans">acanthosis nigricans</a>.</p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=2" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The exact mechanisms of the complex pathways of metabolic syndrome are under investigation. The <a href="/wiki/Pathophysiology" title="Pathophysiology">pathophysiology</a> is very complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>. <a href="/wiki/Stress_(biology)" title="Stress (biology)">Stress</a> can also be a contributing factor. The most important factors are genetics,<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-Groop2000_8-0" class="reference"><a href="#cite_note-Groop2000-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Bouchard1995_9-0" class="reference"><a href="#cite_note-Bouchard1995-9"><span>[</span>9<span>]</span></a></sup> aging, diet (particularly sugar-sweetened beverage consumption),<sup id="cite_ref-PMID20693348_10-0" class="reference"><a href="#cite_note-PMID20693348-10"><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Sedentary_behavior" title="Sedentary behavior" class="mw-redirect">sedentary behavior</a><sup id="cite_ref-PMID22514690_11-0" class="reference"><a href="#cite_note-PMID22514690-11"><span>[</span>11<span>]</span></a></sup> or low physical activity,<sup id="cite_ref-katzmaryk_12-0" class="reference"><a href="#cite_note-katzmaryk-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> disrupted chronobiology/sleep,<sup id="cite_ref-PMID23890470_14-0" class="reference"><a href="#cite_note-PMID23890470-14"><span>[</span>14<span>]</span></a></sup> mood disorders/psychotropic medication use,<sup id="cite_ref-PMID24262678_15-0" class="reference"><a href="#cite_note-PMID24262678-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-PMID23361837_16-0" class="reference"><a href="#cite_note-PMID23361837-16"><span>[</span>16<span>]</span></a></sup> and excessive alcohol use.<sup id="cite_ref-PMID24315622_17-0" class="reference"><a href="#cite_note-PMID24315622-17"><span>[</span>17<span>]</span></a></sup> There is debate regarding whether obesity or insulin resistance is the cause of the metabolic syndrome or if they are consequences of a more far-reaching metabolic derangement. A number of markers of systemic <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>, including <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a>, are often increased, as are <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a>, <a href="/wiki/Interleukin_6" title="Interleukin 6">interleukin 6</a>, <a href="/wiki/Tumor_necrosis_factor-alpha" title="Tumor necrosis factor-alpha" class="mw-redirect">tumor necrosis factor-alpha</a>&#160;(TNFα), and others. Some have pointed to a variety of causes, including increased <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> levels caused by dietary <a href="/wiki/Fructose" title="Fructose">fructose</a>.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></p>
<p>It is generally accepted that the current food environment contributes to the development of metabolic syndrome: our diet is mismatched with our biochemistry.<sup id="cite_ref-PMID22351884_21-0" class="reference"><a href="#cite_note-PMID22351884-21"><span>[</span>21<span>]</span></a></sup> Weight gain is associated with metabolic syndrome. Rather than total adiposity, the core clinical component of the syndrome is visceral and/or ectopic fat (i.e., fat in organs not designed for fat storage) whereas the principal metabolic abnormality is insulin resistance. The continuous provision of energy via dietary carbohydrate, lipid, and protein fuels, unmatched by physical activity/energy demand, arguably creates a backlog of the products of mitochondrial oxidation, a process associated with progressive mitochondrial dysfunction and insulin resistance.</p>
<h3><span class="mw-headline" id="Stress">Stress</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=3" title="Edit section: Stress">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Recent research indicates prolonged chronic <a href="/wiki/Stress_(biology)" title="Stress (biology)">stress</a> can contribute to metabolic syndrome by disrupting the hormonal balance of the <a href="/wiki/Hypothalamic-pituitary-adrenal_axis" title="Hypothalamic-pituitary-adrenal axis" class="mw-redirect">hypothalamic-pituitary-adrenal axis</a> (HPA-axis).<sup id="cite_ref-Gohill_22-0" class="reference"><a href="#cite_note-Gohill-22"><span>[</span>22<span>]</span></a></sup> A dysfunctional HPA-axis causes high <a href="/wiki/Cortisol" title="Cortisol">cortisol</a> levels to circulate, which results in raising <a href="/wiki/Glucose" title="Glucose">glucose</a> and <a href="/wiki/Insulin" title="Insulin">insulin</a> levels, which in turn cause insulin-mediated effects on adipose tissue, ultimately promoting <a href="/wiki/Visceral_adiposity" title="Visceral adiposity" class="mw-redirect">visceral adiposity</a>, insulin resistance, dyslipidemia and hypertension, with direct effects on the bone, causing "low turnover" <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a>.<sup id="cite_ref-tsigos_23-0" class="reference"><a href="#cite_note-tsigos-23"><span>[</span>23<span>]</span></a></sup> HPA-axis dysfunction may explain the reported risk indication of <a href="/wiki/Abdominal_obesity" title="Abdominal obesity">abdominal obesity</a> to <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> (CVD), type 2 diabetes and <a href="/wiki/Stroke" title="Stroke">stroke</a>.<sup id="cite_ref-rosmond_24-0" class="reference"><a href="#cite_note-rosmond-24"><span>[</span>24<span>]</span></a></sup> <a href="/wiki/Psychosocial" title="Psychosocial">Psychosocial</a> stress is also linked to <a href="/wiki/Heart_disease" title="Heart disease" class="mw-redirect">heart disease</a>.<sup id="cite_ref-brunner_25-0" class="reference"><a href="#cite_note-brunner-25"><span>[</span>25<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Overweight">Overweight</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=4" title="Edit section: Overweight">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central obesity</a></div>
<p><a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central obesity</a> is a key feature of the syndrome, reflecting the fact that the syndrome's prevalence is driven by the strong relationship between <a href="/wiki/Waist" title="Waist">waist</a> <a href="/wiki/Circumference" title="Circumference">circumference</a> and increasing adiposity. However, despite the importance of obesity, patients who are of normal weight may also be <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin-resistant</a> and have the syndrome.<sup id="cite_ref-isbn0-07-147692-X_26-0" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Sedentary_lifestyle">Sedentary lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=5" title="Edit section: Sedentary lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Sedentary_lifestyle" title="Sedentary lifestyle">Physical inactivity</a> is a predictor of <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">CVD</a> events and related <a href="/wiki/Death" title="Death">mortality</a>. Many components of metabolic syndrome are associated with a sedentary lifestyle, including increased adipose tissue (predominantly <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">central</a>); reduced <a href="/wiki/HDL_cholesterol" title="HDL cholesterol" class="mw-redirect">HDL cholesterol</a>; and a trend toward increased <a href="/wiki/Triglycerides" title="Triglycerides" class="mw-redirect">triglycerides</a>, <a href="/wiki/Hypertension" title="Hypertension">blood pressure</a>, and <a href="/wiki/Glucose" title="Glucose">glucose</a> in the genetically susceptible. Compared with individuals who watched <a href="/wiki/Television" title="Television">television</a> or <a href="/wiki/Videotape" title="Videotape">videos</a> or used their <a href="/wiki/Computer" title="Computer">computers</a> for less than one hour daily, those who carried out these behaviors for greater than four hours daily have a twofold increased <a href="/wiki/Risk" title="Risk">risk</a> of metabolic syndrome.<sup id="cite_ref-isbn0-07-147692-X_26-1" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Aging">Aging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=6" title="Edit section: Aging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Metabolic syndrome affects 44% of the U.S. population older than age 50. With respect to that demographic, the percentage of women having the syndrome is higher than that of men. The age dependency of the syndrome's prevalence is seen in most populations around the world.<sup id="cite_ref-isbn0-07-147692-X_26-2" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Diabetes_mellitus_type_2">Diabetes mellitus type 2</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=7" title="Edit section: Diabetes mellitus type 2">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">Diabetes mellitus</a></div>
<p>The metabolic syndrome quintuples the risk of type 2 diabetes mellitus. Type 2 diabetes is considered a <a href="/wiki/Complication_(medicine)" title="Complication (medicine)">complication</a> of metabolic syndrome. In people with impaired glucose tolerance or impaired fasting glucose, presence of metabolic syndrome doubles the risk of developing type 2 diabetes.<sup id="cite_ref-PMID22895669_27-0" class="reference"><a href="#cite_note-PMID22895669-27"><span>[</span>27<span>]</span></a></sup> It is likely that prediabetes and metabolic syndrome denote the same disorder, defining it by the different sets of biological markers. The presence of metabolic syndrome is associated with a higher prevalence of CVD than found in patients with type 2 diabetes or <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">IGT</a> without the syndrome.<sup id="cite_ref-isbn0-07-147692-X_26-3" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup> <a href="/wiki/Adiponectin#Hypoadiponectinemia" title="Adiponectin">Hypoadiponectinemia</a> has been shown to increase <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>,<sup id="cite_ref-pmid17495599_28-0" class="reference"><a href="#cite_note-pmid17495599-28"><span>[</span>28<span>]</span></a></sup> and is considered to be a <a href="/wiki/Risk_factor" title="Risk factor">risk factor</a> for developing metabolic syndrome.<sup id="cite_ref-pmid19258676_29-0" class="reference"><a href="#cite_note-pmid19258676-29"><span>[</span>29<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Coronary_heart_disease">Coronary heart disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=8" title="Edit section: Coronary heart disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Coronary_disease" title="Coronary disease" class="mw-redirect">Coronary disease</a></div>
<p>The approximate prevalence of the metabolic syndrome in patients with <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a> (CHD) is 50%, with a prevalence of 37% in patients with premature <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a> (age 45), particularly in women. With appropriate <a href="/wiki/Cardiopulmonary_Rehabilitation" title="Cardiopulmonary Rehabilitation" class="mw-redirect">cardiac rehabilitation</a> and changes in <a href="/wiki/Lifestyle_(sociology)" title="Lifestyle (sociology)">lifestyle</a> (e.g., <a href="/wiki/Nutrition" title="Nutrition">nutrition</a>, <a href="/wiki/Physical_activity" title="Physical activity" class="mw-redirect">physical activity</a>, <a href="/wiki/Weight" title="Weight">weight</a> reduction, and, in some cases, <a href="/wiki/Drugs" title="Drugs" class="mw-redirect">drugs</a>), the prevalence of the syndrome can be reduced.<sup id="cite_ref-isbn0-07-147692-X_26-4" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lipodystrophy">Lipodystrophy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=9" title="Edit section: Lipodystrophy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Lipodystrophy" title="Lipodystrophy">Lipodystrophy</a></div>
<p>Lipodystrophic disorders in general are associated with metabolic syndrome. Both genetic (e.g., <a href="/wiki/Berardinelli-Seip_congenital_lipodystrophy" title="Berardinelli-Seip congenital lipodystrophy" class="mw-redirect">Berardinelli-Seip congenital lipodystrophy</a>, <a href="/wiki/Dunnigan_familial_partial_lipodystrophy" title="Dunnigan familial partial lipodystrophy">Dunnigan familial partial lipodystrophy</a>) and <a href="/wiki/Acquired" title="Acquired" class="mw-redirect">acquired</a> (e.g., <a href="/wiki/HIV" title="HIV">HIV</a>-related <a href="/wiki/Lipodystrophy" title="Lipodystrophy">lipodystrophy</a> in patients treated with highly active <a href="/wiki/Antiretroviral_therapy" title="Antiretroviral therapy" class="mw-redirect">antiretroviral therapy</a>) forms of lipodystrophy may give rise to severe <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> and many of metabolic syndrome's components.<sup id="cite_ref-isbn0-07-147692-X_26-5" class="reference"><a href="#cite_note-isbn0-07-147692-X-26"><span>[</span>26<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Psychiatric_illnesses">Psychiatric illnesses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=10" title="Edit section: Psychiatric illnesses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>People with <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, <a href="/wiki/Schizoaffective_disorder" title="Schizoaffective disorder">schizoaffective disorder</a> or <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a> may have a predisposition to metabolic syndrome that is <a href="/wiki/Exacerbate" title="Exacerbate" class="mw-redirect">exacerbated</a> by sedentary lifestyle, poor dietary habits, possible limited access to care, and antipsychotic drug-induced adverse effects. It has been found in Australia that 67% of patients with either bipolar disorder or schizoaffective disorder, and 51%<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> of patients with schizophrenia meet criteria for metabolic syndrome; the prevalence is higher in women than in men.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=11" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>It is common for there to be a development of <a href="/wiki/Visceral_fat" title="Visceral fat" class="mw-redirect">visceral fat</a>, after which the <a href="/wiki/Adipocyte" title="Adipocyte">adipocytes</a> (fat cells) of the visceral fat increase <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> levels of TNFα and alter levels of a number of other substances (e.g., <a href="/wiki/Adiponectin" title="Adiponectin">adiponectin</a>, <a href="/wiki/Resistin" title="Resistin">resistin</a>, and <a href="/wiki/PAI-1" title="PAI-1" class="mw-redirect">PAI-1</a>). TNFα has been shown not only to cause the production of inflammatory <a href="/wiki/Cytokine" title="Cytokine">cytokines</a>, but also possibly to trigger cell signaling by interaction with a TNFα <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a> that may lead to insulin resistance.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> An experiment with rats fed a diet with 33% <a href="/wiki/Sucrose" title="Sucrose">sucrose</a> has been proposed as a model for the development of metabolic syndrome. The sucrose first elevated blood levels of <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>, which induced <a href="/wiki/Visceral" title="Visceral" class="mw-redirect">visceral</a> fat and ultimately resulted in insulin resistance.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> The progression from visceral fat to increased TNFα to insulin resistance has some parallels to human development of metabolic syndrome. The increase in adipose tissue also increases the number of immune cells present within, which play a role in inflammation. Chronic inflammation contributes to an increased risk of hypertension, atherosclerosis and diabetes.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<p>The central role of the <a href="/wiki/Cannabinoid" title="Cannabinoid">cannabinoid</a> system in the development of metabolic syndrome is indisputable. Endocannabinoid overproduction and dysbalance may exacerbate corticolimbic reward system dysfunction, and contribute to executive dysfunction (e.g., impaired delay discounting), perpetuating unhealthy behaviors. The brain is crucial in development of metabolic syndrome, modulating peripheral carbohydrate and lipid metabolism.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2015)">citation needed</span></a></i>]</sup></p>
<p>Metabolic syndrome is a risk factor for <a href="/wiki/Neurological_disorders" title="Neurological disorders" class="mw-redirect">neurological disorders</a>.<sup id="cite_ref-Farooqui_35-0" class="reference"><a href="#cite_note-Farooqui-35"><span>[</span>35<span>]</span></a></sup></p>
<p>The metabolic syndrome can be induced by overfeeding with sugar or fructose, particularly concomitantly with high-fat diet.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2014)">citation needed</span></a></i>]</sup> The resulting short-chain fatty acid production, and general oversupply of n-6 fatty acids are important determinants of metabolic syndrome. In particular, <a href="/wiki/Arachidonic_acid" title="Arachidonic acid">arachidonic acid</a> metabolism appears to be a factor in the pathogenesis of metabolic syndrome: arachidonic acid (with its precursor - <a href="/wiki/Linoleic_acid" title="Linoleic acid">linoleic acid</a>) serve as a substrate to <a href="/wiki/Inflammation" title="Inflammation">inflammatory factor</a> production (<a href="/wiki/Prostaglandin" title="Prostaglandin">prostaglandins</a> and <a href="/wiki/Leukotriene" title="Leukotriene">leukotrienes</a>), whereas arachidonic acid-containing <a href="/wiki/Diacylglycerol" title="Diacylglycerol" class="mw-redirect">diacylglycerol</a> (DAG) is a precursor to the endocannabinoid (2-arachidonoylglycerol) and is a by-product of fatty acid amide hydrolase (<a href="/wiki/FAAH" title="FAAH" class="mw-redirect">FAAH</a>)- mediated metabolism of <a href="/wiki/Anandamide" title="Anandamide">anandamide</a> (produced from N-arachidonoyl phosphatidylethanolamine).</p>
<p><a href="/wiki/Metabolome" title="Metabolome">Metabolomic</a> studies suggest an excess of organic acids, impaired <a href="/wiki/Lipid_oxidation" title="Lipid oxidation" class="mw-redirect">lipid oxidation</a> byproducts, <a href="/wiki/Essential_fatty_acids" title="Essential fatty acids" class="mw-redirect">essential fatty acids</a> and <a href="/wiki/Essential_amino_acids" title="Essential amino acids" class="mw-redirect">essential amino acids</a> in the <a href="/wiki/Blood_serum" title="Blood serum" class="mw-redirect">blood serum</a> of affected patients. However, it is not entirely clear whether the accumulation of essential fatty acids and amino acids is the result of excessive ingestion or excess production by <a href="/wiki/Gut_bacteria" title="Gut bacteria" class="mw-redirect">gut microbiota</a>.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=12" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity published a guideline to harmonize the definition of the metabolic syndrome.<sup id="cite_ref-PMID20870782_36-0" class="reference"><a href="#cite_note-PMID20870782-36"><span>[</span>36<span>]</span></a></sup> This definition recognizes that the risk associated with a particular waist measurement will differ in different populations. Whether it is better at this time to set the level at which risk starts to increase or at which there is already substantially increased risk will be up to local decision-making groups. However, for international comparisons and to facilitate the etiology, it is critical that a commonly agreed-upon set of criteria be used worldwide, with agreed-upon cut points for different ethnic groups and sexes. There are many people in the world of mixed ethnicity, and in those cases, pragmatic decisions will have to be made.</p>
<p>The previous definitions of the metabolic syndrome by the <a href="/wiki/International_Diabetes_Federation" title="International Diabetes Federation">International Diabetes Federation</a><sup id="cite_ref-idf.org_37-0" class="reference"><a href="#cite_note-idf.org-37"><span>[</span>37<span>]</span></a></sup> and the revised <a href="/wiki/National_Cholesterol_Education_Program" title="National Cholesterol Education Program">National Cholesterol Education Program</a> are very similar and they identify individuals with a given set of symptoms as having metabolic syndrome. There are two differences, however: the IDF definition states that if <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a> (BMI) is greater than 30&#160;kg/m<sup>2</sup>, <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">central obesity</a> can be assumed, and waist circumference does not need to be measured. However, this potentially excludes any subject without increased waist circumference if BMI is less than 30. Conversely, the NCEP definition indicates that metabolic syndrome can be diagnosed based on other criteria. Also, the IDF uses geography-specific cut points for waist circumference, while NCEP uses only one set of cut points for waist circumference regardless of geography. These two definitions are much more similar than the original NCEP and WHO definitions.</p>
<h3><span class="mw-headline" id="IDF">IDF</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=13" title="Edit section: IDF">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/International_Diabetes_Federation" title="International Diabetes Federation">International Diabetes Federation</a><sup id="cite_ref-idf.org_37-1" class="reference"><a href="#cite_note-idf.org-37"><span>[</span>37<span>]</span></a></sup> consensus worldwide definition of the metabolic syndrome (2006) is: Central obesity (defined as waist circumference<sup>#</sup> with ethnicity-specific values) AND any two of the following:</p>
<ul>
<li>Raised triglycerides: &gt; 150&#160;mg/dL (1.7&#160;mmol/L), or specific treatment for this lipid abnormality</li>
<li>Reduced <a href="/wiki/HDL_cholesterol" title="HDL cholesterol" class="mw-redirect">HDL cholesterol</a>: &lt; 40&#160;mg/dL (1.03&#160;mmol/L) in males, &lt; 50&#160;mg/dL (1.29&#160;mmol/L) in females, or specific treatment for this lipid abnormality</li>
<li>Raised blood pressure (BP): systolic BP &gt; 130 or diastolic BP &gt;85&#160;mm Hg, or treatment of previously diagnosed hypertension</li>
<li>Raised fasting plasma glucose (FPG): &gt;100&#160;mg/dL (5.6&#160;mmol/L), or previously diagnosed type 2 diabetes</li>
</ul>
<p>If FPG is &gt;5.6&#160;mmol/L or 100&#160;mg/dL, an oral <a href="/wiki/Glucose_tolerance_test" title="Glucose tolerance test">glucose tolerance test</a> is strongly recommended, but is not necessary to define presence of the syndrome.<br />
<sup>#</sup> If BMI is &gt;30&#160;kg/m², central obesity can be assumed and waist circumference does not need to be measured</p>
<h3><span class="mw-headline" id="WHO">WHO</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=14" title="Edit section: WHO">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> 1999 criteria<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup> require the presence of any one of diabetes mellitus, impaired <a href="/wiki/Glucose_tolerance" title="Glucose tolerance" class="mw-redirect">glucose tolerance</a>, impaired fasting glucose or <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>, AND two of the following:</p>
<ul>
<li>Blood pressure: ≥ 140/90 mmHg</li>
<li><a href="/wiki/Dyslipidemia" title="Dyslipidemia">Dyslipidemia</a>: triglycerides (TG): ≥ 1.695&#160;mmol/L and high-density <a href="/wiki/Lipoprotein" title="Lipoprotein">lipoprotein</a> cholesterol (HDL-C) ≤ 0.9&#160;mmol/L (male), ≤ 1.0&#160;mmol/L (female)</li>
<li>Central obesity: waist:hip ratio &gt; 0.90 (male); &gt; 0.85 (female), or body mass index &gt; 30&#160;kg/m<sup>2</sup></li>
<li><a href="/wiki/Microalbuminuria" title="Microalbuminuria">Microalbuminuria</a>: urinary albumin excretion ratio ≥ 20&#160;µg/min or albumin:creatinine ratio ≥ 30&#160;mg/g</li>
</ul>
<h3><span class="mw-headline" id="EGIR">EGIR</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=15" title="Edit section: EGIR">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/w/index.php?title=European_Group_for_the_Study_of_Insulin_Resistance&amp;action=edit&amp;redlink=1" class="new" title="European Group for the Study of Insulin Resistance (page does not exist)">European Group for the Study of Insulin Resistance</a> (1999) requires insulin resistance defined as the top 25% of the fasting insulin values among nondiabetic individuals AND two or more of the following:</p>
<ul>
<li>Central obesity: waist circumference ≥ 94&#160;cm or 37 inches (male), ≥ 80&#160;cm or 31.5 inches (female)</li>
<li>Dyslipidemia: TG ≥ 2.0&#160;mmol/L and/or HDL-C &lt; 1.0&#160;mmol/L or treated for dyslipidemia</li>
<li>Hypertension: blood pressure ≥ 140/90 mmHg or antihypertensive medication</li>
<li>Fasting plasma glucose ≥ 6.1&#160;mmol/L</li>
</ul>
<h3><span class="mw-headline" id="NCEP">NCEP</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=16" title="Edit section: NCEP">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The US National Cholesterol Education Program Adult Treatment Panel III (2001) requires at least three of the following:<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup></p>
<ul>
<li>Central obesity: waist circumference ≥ 102&#160;cm or 40&#160;inches (male), ≥ 88&#160;cm or 35&#160;inches(female)</li>
<li>Dyslipidemia: TG ≥ 1.7&#160;mmol/L (150&#160;mg/dl)</li>
<li>Dyslipidemia: HDL-C &lt; 40&#160;mg/dL (male), &lt; 50&#160;mg/dL (female)</li>
<li>Blood pressure ≥ 130/85 mmHg (or treated for hypertension)</li>
<li>Fasting plasma glucose ≥ 6.1&#160;mmol/L (110&#160;mg/dl)</li>
</ul>
<h3><span class="mw-headline" id="American_Heart_Association">American Heart Association</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=17" title="Edit section: American Heart Association">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is confusion as to whether, in 2004, the AHA/NHLBI intended to create another set of guidelines or simply update the NCEP ATP III definition.<sup id="cite_ref-Grundy_40-0" class="reference"><a href="#cite_note-Grundy-40"><span>[</span>40<span>]</span></a></sup><sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup></p>
<ul>
<li>Elevated waist circumference:
<ul>
<li>Men — greater than 40&#160;inches (102&#160;cm)</li>
<li>Women — greater than 35&#160;inches (88&#160;cm)</li>
</ul>
</li>
<li>Elevated triglycerides: Equal to or greater than 150&#160;mg/dL (1.7&#160;mmol/L)</li>
<li>Reduced HDL ("good") cholesterol:
<ul>
<li>Men — Less than 40&#160;mg/dL (1.03&#160;mmol/L)</li>
<li>Women — Less than 50&#160;mg/dL (1.29&#160;mmol/L)</li>
</ul>
</li>
<li>Elevated blood pressure: Equal to or greater than 130/85&#160;mm Hg or use of medication for hypertension</li>
<li>Elevated fasting glucose: Equal to or greater than 100&#160;mg/dL (5.6&#160;mmol/L) or use of medication for hyperglycemia</li>
</ul>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=18" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/C-reactive_protein" title="C-reactive protein">High-sensitivity C-reactive protein</a> has been developed and used as a marker to predict coronary vascular diseases in metabolic syndrome, and it was recently used as a predictor for <a href="/wiki/NAFLD" title="NAFLD" class="mw-redirect">nonalcoholic fatty liver disease</a> (steatohepatitis) in correlation with serum markers that indicated lipid and glucose metabolism.<sup id="cite_ref-pmid19271113_42-0" class="reference"><a href="#cite_note-pmid19271113-42"><span>[</span>42<span>]</span></a></sup> Fatty liver disease and steatohepatitis can be considered as manifestations of metabolic syndrome, indicative of abnormal energy storage as fat in ectopic distribution. Reproductive disorders (such as <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> in women of reproductive age), and erectile dysfunction or decreased total testosterone (low testosterone-binding globulin) in men can be attributed to metabolic syndrome.<sup id="cite_ref-PMID20870782_36-1" class="reference"><a href="#cite_note-PMID20870782-36"><span>[</span>36<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Rheumatic_diseases">Rheumatic diseases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=19" title="Edit section: Rheumatic diseases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There are new findings regarding the comorbidity associated with rheumatic diseases. Both <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a> and <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a> have been found to be associated with metabolic syndrome.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=20" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Various strategies have been proposed to prevent the development of metabolic syndrome. These include increased physical activity (such as walking 30 minutes every day),<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup> and a healthy, reduced calorie diet.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span>[</span>45<span>]</span></a></sup> Many studies support the value of a healthy lifestyle as above. However, one study stated these potentially beneficial measures are effective in only a minority of people, primarily due to a lack of compliance with lifestyle and diet changes.<sup id="cite_ref-katzmaryk_12-1" class="reference"><a href="#cite_note-katzmaryk-12"><span>[</span>12<span>]</span></a></sup> The <a href="/wiki/International_Obesity_Taskforce" title="International Obesity Taskforce">International Obesity Taskforce</a> states that interventions on a sociopolitical level are required to reduce development of the metabolic syndrome in populations.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup></p>
<p>The <a href="/wiki/Caerphilly_Heart_Disease_Study" title="Caerphilly Heart Disease Study">Caerphilly Heart Disease Study</a> followed 2,375 male subjects over 20 years and suggested the daily intake of a pint (~568 ml) of milk or equivalent dairy products more than halved the risk of metabolic syndrome.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup> Some subsequent studies support the authors' findings, while others dispute them.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=21" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first line treatment is change of lifestyle (e.g., Dietary Guidelines for Americans and physical activity). However, if in three to six months of efforts at remedying risk factors prove insufficient, then drug treatment is frequently required. Generally, the individual disorders that compose the metabolic syndrome are treated separately. <a href="/wiki/Diuretic" title="Diuretic">Diuretics</a> and <a href="/wiki/ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a> may be used to treat <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>. Cholesterol drugs may be used to lower LDL cholesterol and triglyceride levels, if they are elevated, and to raise HDL levels if they are low. Use of drugs that decrease insulin resistance, e.g., <a href="/wiki/Metformin" title="Metformin">metformin</a> and <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>, is controversial; this treatment is not approved by the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration" class="mw-redirect">U.S. Food and Drug Administration</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2012)">citation needed</span></a></i>]</sup> Weight loss medications may result in weight loss.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> As obesity is often recognized as the culprit behind many of the additional symptoms, with weight loss and lifestyle changes in diet, physical activity, the need for other medications may diminish.</p>
<p>A 2003 study indicated cardiovascular exercise was therapeutic in approximately 31% of cases. The most probable benefit was to triglyceride levels, with 43% showing improvement; but fasting plasma glucose and insulin resistance of 91% of test subjects did not improve.<sup id="cite_ref-katzmaryk_12-2" class="reference"><a href="#cite_note-katzmaryk-12"><span>[</span>12<span>]</span></a></sup> Many other studies have supported the value of physical activity and dietary modifications to treat metabolic syndrome. Some natural compounds, like <a href="/wiki/Ursolic_acid" title="Ursolic acid">ursolic acid</a>, have been suggested as a treatment for obesity/metabolic syndrome based on the results of extensive research involving animal models; it is argued, however, that there is still a lack of data regarding the use of ursolic acid in humans, as phase-II/III trials of that drug have not been carried so far.<sup id="cite_ref-10.13140.2FRG.2.1.4502.4804_2-1" class="reference"><a href="#cite_note-10.13140.2FRG.2.1.4502.4804-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Restricting the overall dietary carbohydrate intake is more effective in reducing the most common symptoms of metabolic syndrome than the more commonly prescribed reduction in dietary fat intake.<sup id="cite_ref-n.26m2005_50-0" class="reference"><a href="#cite_note-n.26m2005-50"><span>[</span>50<span>]</span></a></sup></p>
<p>The combination preparation <a href="/wiki/Simvastatin/sitagliptin" title="Simvastatin/sitagliptin">simvastatin/sitagliptin</a> (marketed as Juvisync) was introduced in 2011 and the use of this drug was to lower LDL levels and as well as increase insulin levels.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup> This drug could have been used to treat metabolic syndrome but was removed from the market by Merck in 2013 due to business reasons.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span>[</span>52<span>]</span></a></sup></p>
<p>High-dose statins, recommended to reduce cardiovascular risk, have been associated with higher progression to diabetes, particularly in patients with metabolic syndrome. The biological mechanisms are not entirely understood, however, the plausible explanation may lie in competitive inhibition of glucose transport via the solute carrier (SLC) family of transporters (specifically <i><a href="/wiki/SLCO1B1" title="SLCO1B1">SLCO1B1</a></i>), important in statin pharmacokinetics.</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=22" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Epidemiology_of_metabolic_syndrome" title="Epidemiology of metabolic syndrome">Epidemiology of metabolic syndrome</a></div>
<p>Approximately 20 – 25 percent of the world’s adult population has the cluster of risk factors that is metabolic syndrome.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup> In 2000, approximately 32% of U.S. adults had the metabolic syndrome.<sup id="cite_ref-Ford_ES_54-0" class="reference"><a href="#cite_note-Ford_ES-54"><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-Ford_ES_et_al_55-0" class="reference"><a href="#cite_note-Ford_ES_et_al-55"><span>[</span>55<span>]</span></a></sup> In more recent years that figure has climbed to 34%.<sup id="cite_ref-Ford_ES_et_al_55-1" class="reference"><a href="#cite_note-Ford_ES_et_al-55"><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=23" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The term "metabolic syndrome" dates back to at least the late 1950s, but came into common usage in the late 1970s to describe various associations of risk factors with diabetes that had been noted as early as the 1920s.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup></p>
<ul>
<li>The Marseilles physician Dr. Jean Vague, in 1947, observed that upper body obesity appeared to predispose to <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>, <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, <a href="/wiki/Gout" title="Gout">gout</a> and <a href="/wiki/Calculus_(medicine)" title="Calculus (medicine)">calculi</a>.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup></li>
<li>Avogadro, Crepaldi and coworkers described six moderately obese patients with diabetes, <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>, and marked <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">hypertriglyceridemia</a>, all of which improved when the patients were put on a hypocaloric, low-carbohydrate diet.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup></li>
<li>In 1977, Haller used the term "metabolic syndrome" for associations of <a href="/wiki/Obesity" title="Obesity">obesity</a>, <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a>, <a href="/wiki/Hyperlipoproteinemia" title="Hyperlipoproteinemia" class="mw-redirect">hyperlipoproteinemia</a>, <a href="/wiki/Hyperuricemia" title="Hyperuricemia">hyperuricemia</a>, and <a href="/wiki/Hepatic_steatosis" title="Hepatic steatosis" class="mw-redirect">hepatic steatosis</a> when describing the additive effects of risk factors on atherosclerosis.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup></li>
<li>The same year, Singer used the term for associations of obesity, gout, diabetes mellitus, and <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> with hyperlipoproteinemia.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></li>
<li>In 1977 and 1978, Gerald B. Phillips developed the concept that risk factors for <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> concur to form a "constellation of abnormalities" (i.e., <a href="/wiki/Glucose_intolerance" title="Glucose intolerance" class="mw-redirect">glucose intolerance</a>, <a href="/wiki/Hyperinsulinemia" title="Hyperinsulinemia">hyperinsulinemia</a>, <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>, <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">hypertriglyceridemia</a>, and hypertension) associated not only with heart disease, but also with aging, obesity and other clinical states. He suggested there must be an underlying linking factor, the identification of which could lead to the prevention of cardiovascular disease; he hypothesized that this factor was <a href="/wiki/Sex_hormones" title="Sex hormones" class="mw-redirect">sex hormones</a>.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup></li>
<li>In 1988, in his <a href="/wiki/Banting_Lectures" title="Banting Lectures">Banting lecture</a>, <a href="/wiki/Gerald_M._Reaven" title="Gerald M. Reaven" class="mw-redirect">Gerald M. Reaven</a> proposed <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> as the underlying factor and named the constellation of abnormalities syndrome X. Reaven did not include abdominal obesity, which has also been hypothesized as the underlying factor, as part of the condition.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup></li>
</ul>
<p>The terms "metabolic syndrome," "insulin resistance syndrome," and "syndrome X" are now used specifically to define a constellation of abnormalities associated with increased risk for the development of type 2 diabetes and atherosclerotic vascular disease (e.g., heart disease and stroke).</p>
<h2><span class="mw-headline" id="Controversy">Controversy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=24" title="Edit section: Controversy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The clinical value of using "metabolic syndrome" as a diagnosis previously has been debated due to different sets of conflicting and incomplete diagnostic criteria. These concerns have led the <a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a> and the <a href="/wiki/European_Association_for_the_Study_of_Diabetes" title="European Association for the Study of Diabetes">European Association for the Study of Diabetes</a> to issue a joint statement identifying eight major concerns on the clinical utility of the metabolic syndrome diagnosis.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup> The principal argument has been that when confounding factors such as obesity are accounted for, diagnosis of the metabolic syndrome has a negligible association with the risk of heart disease.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup></p>
<p>Naturally, since the metabolic syndrome is a disorder of energy distribution and storage, fat accumulation explains for a significant proportion of cardiovascular risk. However, obesity without metabolic syndrome does not confer a significant cardiovascular risk, whereas metabolic syndrome without obesity is associated with a significant risk of diabetes and cardiovascular disease. This association of metabolic syndrome with diabetes can be illustrated by generalized <a href="/wiki/Lipodystrophy" title="Lipodystrophy">lipodystrophy</a> (near complete absence of adipose tissue). The animals and humans with generalized lipodystrophy develop signs of metabolic syndrome in the absence of adipose tissue; and the metabolic syndrome progresses to type&#160;2 diabetes. Adipose tissue transplantation in transgenic mice with lipodystrophy can cure the type&#160;2 diabetes. It has not been contested that cardiovascular risk factors tend to cluster together; the matter of contention has been the assertion that the metabolic syndrome is anything more than the sum of its constituent parts. <a href="/wiki/Phenotypic_heterogeneity" title="Phenotypic heterogeneity">Phenotypic heterogeneity</a> (for example, represented by variation in metabolic syndrome factor combinations among individuals with metabolic syndrome) has fueled that debate. However, more recent evidence suggests that common triggers (for example, excessive sugar-intake in the environment of overabundant food) can contribute to the development of multiple metabolic abnormalities at the same time, supporting the commonality of the energy utilization and storage pathways in metabolic syndrome.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=25" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-pmid24711954-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24711954_1-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kaur J (2014). <a rel="nofollow" class="external text" href="http://www.hindawi.com/journals/crp/2014/943162/">"A comprehensive review on metabolic syndrome"</a>. <i>CARDIOLOGY RESEARCH AND PRACTICE</i> <b>2014</b>: 943162. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1155%2F2014%2F943162">10.1155/2014/943162</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3966331">3966331</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24711954">24711954</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=A+comprehensive+review+on+metabolic+syndrome&amp;rft.au=Kaur+J&amp;rft.aulast=Kaur+J&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fcrp%2F2014%2F943162%2F&amp;rft_id=info%3Adoi%2F10.1155%2F2014%2F943162&amp;rft_id=info%3Apmc%2F3966331&amp;rft_id=info%3Apmid%2F24711954&amp;rft.jtitle=CARDIOLOGY+RESEARCH+AND+PRACTICE&amp;rft.pages=943162&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2014" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10.13140.2FRG.2.1.4502.4804-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-10.13140.2FRG.2.1.4502.4804_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10.13140.2FRG.2.1.4502.4804_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Felizola SJA (2015). "Ursolic acid in experimental models and human subjects: potential as an anti-obesity/overweight treatment?". <i>ResearchGate</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.13140%2FRG.2.1.4502.4804">10.13140/RG.2.1.4502.4804</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Ursolic+acid+in+experimental+models+and+human+subjects%3A+potential+as+an+anti-obesity%2Foverweight+treatment%3F&amp;rft.au=Felizola+SJA&amp;rft.aulast=Felizola+SJA&amp;rft.date=2015&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.13140%2FRG.2.1.4502.4804&amp;rft.jtitle=ResearchGate.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Ford ES, Giles WH, Dietz WH (2002). "Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey". <i>JAMA</i> <b>287</b> (3): 356–359. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.287.3.356">10.1001/jama.287.3.356</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11790215">11790215</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Prevalence+of+metabolic+syndrome+among+US+adults%3A+findings+from+the+third+National+Health+and+Nutrition+Examination+Survey&amp;rft.au=Ford+ES%2C+Giles+WH%2C+Dietz+WH&amp;rft.aulast=Ford+ES%2C+Giles+WH%2C+Dietz+WH&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.287.3.356&amp;rft_id=info%3Apmid%2F11790215&amp;rft.issue=3&amp;rft.jtitle=JAMA&amp;rft.pages=356-359&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=287" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text">In his <a rel="nofollow" class="external text" href="http://www.agale.com.au/CFS.htm">case studies poster</a> presented at the Chronic Fatigue Syndrome Conference in Sydney, Australia (February 12–13, 1998), Dr Allen E. Gale, Consultant Physician (Allergy), identifies the acronym CHAOS as an abbreviation for Coronary artery disease, Hypertension, Atherosclerosis, Obesity, and Stroke.</span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.diabetes.co.uk/diabetes-and-metabolic-syndrome.html">Metabolic syndrome symptoms</a></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Pollex, R.L.; Hegele, R.A. (2006). "Genetic determinants of the metabolic syndrome". <i>Nat Clin Pract Cardiovasc Med</i> <b>3</b> (9): 482–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fncpcardio0638">10.1038/ncpcardio0638</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16932765">16932765</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Genetic+determinants+of+the+metabolic+syndrome&amp;rft.aufirst=R.L.&amp;rft.au=Hegele%2C+R.A.&amp;rft.aulast=Pollex&amp;rft.au=Pollex%2C+R.L.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fncpcardio0638&amp;rft_id=info%3Apmid%2F16932765&amp;rft.issue=9&amp;rft.jtitle=Nat+Clin+Pract+Cardiovasc+Med&amp;rft.pages=482-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Poulsen, P.; Vaag, A.; Kyvik, K.; Beck-Nielsen, H. (2001). <a rel="nofollow" class="external text" href="http://www.springerlink.com/content/v48xjynabuvplre9/">"Genetic versus environmental aetiology of the metabolic syndrome among male and female twins"</a>. <i>Diabetologia</i> <b>44</b> (5): 537–543. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs001250051659">10.1007/s001250051659</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11380071">11380071</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Genetic+versus+environmental+aetiology+of+the+metabolic+syndrome+among+male+and+female+twins&amp;rft.au=Beck-Nielsen%2C+H.&amp;rft.aufirst=P.&amp;rft.au=Kyvik%2C+K.&amp;rft.aulast=Poulsen&amp;rft.au=Poulsen%2C+P.&amp;rft.au=Vaag%2C+A.&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv48xjynabuvplre9%2F&amp;rft_id=info%3Adoi%2F10.1007%2Fs001250051659&amp;rft_id=info%3Apmid%2F11380071&amp;rft.issue=5&amp;rft.jtitle=Diabetologia&amp;rft.pages=537-543&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Groop2000-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Groop2000_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Groop, Leif (2000). <a rel="nofollow" class="external text" href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&amp;aid=883692">"Genetics of the metabolic syndrome"</a>. <i>British Journal of Nutrition</i> <b>83</b> (83): S39–S48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0007114500000945">10.1017/S0007114500000945</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Genetics+of+the+metabolic+syndrome&amp;rft.au=Groop%2C+Leif&amp;rft.aulast=Groop%2C+Leif&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjournals.cambridge.org%2Faction%2FdisplayAbstract%3FfromPage%3Donline%26aid%3D883692&amp;rft_id=info%3Adoi%2F10.1017%2FS0007114500000945&amp;rft.issue=83&amp;rft.jtitle=British+Journal+of+Nutrition&amp;rft.pages=S39-S48&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=83" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bouchard1995-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bouchard1995_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bouchard, G. (1995). <a rel="nofollow" class="external text" href="http://cat.inist.fr/?aModele=afficheN">"Genetics and the metabolic syndrome"</a>. <i>International journal of obesity</i> <b>19</b>: 52–59<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-04-29</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Genetics+and+the+metabolic+syndrome&amp;rft.au=Bouchard%2C+G.&amp;rft.aulast=Bouchard%2C+G.&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcat.inist.fr%2F%3FaModele%3DafficheN&amp;rft.jtitle=International+journal+of+obesity&amp;rft.pages=52-59&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID20693348-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID20693348_10-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2963518">"Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis"</a>. <i>Diabetes Care</i> <b>33</b> (11): 2477–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdc10-1079">10.2337/dc10-1079</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2963518">2963518</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20693348">20693348</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Sugar-sweetened+beverages+and+risk+of+metabolic+syndrome+and+type+2+diabetes%3A+a+meta-analysis&amp;rft.aulast=Malik+VS%2C+Popkin+BM%2C+Bray+GA%2C+Despr%C3%A9s+JP%2C+Willett+WC%2C+Hu+FB&amp;rft.au=Malik+VS%2C+Popkin+BM%2C+Bray+GA%2C+Despr%C3%A9s+JP%2C+Willett+WC%2C+Hu+FB&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2963518&amp;rft_id=info%3Adoi%2F10.2337%2Fdc10-1079&amp;rft_id=info%3Apmc%2F2963518&amp;rft_id=info%3Apmid%2F20693348&amp;rft.issue=11&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=2477-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID22514690-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID22514690_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, Yates T, Biddle SJ (2012). "Association of sedentary behaviour with metabolic syndrome: a meta-analysis.". <i>PLoS One.</i> <b>7</b> (4): e34916. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0034916">10.1371/journal.pone.0034916</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22514690">22514690</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Association+of+sedentary+behaviour+with+metabolic+syndrome%3A+a+meta-analysis.&amp;rft.au=Edwardson+CL%2C+Gorely+T%2C+Davies+MJ%2C+Gray+LJ%2C+Khunti+K%2C+Wilmot+EG%2C+Yates+T%2C+Biddle+SJ&amp;rft.aulast=Edwardson+CL%2C+Gorely+T%2C+Davies+MJ%2C+Gray+LJ%2C+Khunti+K%2C+Wilmot+EG%2C+Yates+T%2C+Biddle+SJ&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0034916&amp;rft_id=info%3Apmid%2F22514690&amp;rft.issue=4&amp;rft.jtitle=PLoS+One.&amp;rft.pages=e34916&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-katzmaryk-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-katzmaryk_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-katzmaryk_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-katzmaryk_12-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Katzmaryk,, Peter T; Leon, Arthur S.; Wilmore, Jack H.; Skinner, James S.; Rao, D. C.; Rankinen, Tuomo; Bouchard, Claude (October 2003). <a rel="nofollow" class="external text" href="http://www.ms-se.com/pt/re/msse/abstract.00005768-200310000-00013.htm">"Targeting the Metabolic Syndrome with Exercise: Evidence from the HERITAGE Family Study"</a>. <i>Med. Sci. Sports Exerc</i> <b>35</b> (10): 1703–1709. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1249%2F01.MSS.0000089337.73244.9B">10.1249/01.MSS.0000089337.73244.9B</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14523308">14523308</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2007-06-24</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Targeting+the+Metabolic+Syndrome+with+Exercise%3A+Evidence+from+the+HERITAGE+Family+Study&amp;rft.au=Bouchard%2C+Claude&amp;rft.aufirst=Peter+T&amp;rft.au=Katzmaryk%2C%2C+Peter+T&amp;rft.aulast=Katzmaryk%2C&amp;rft.au=Leon%2C+Arthur+S.&amp;rft.au=Rankinen%2C+Tuomo&amp;rft.au=Rao%2C+D.+C.&amp;rft.au=Skinner%2C+James+S.&amp;rft.au=Wilmore%2C+Jack+H.&amp;rft.date=October+2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ms-se.com%2Fpt%2Fre%2Fmsse%2Fabstract.00005768-200310000-00013.htm&amp;rft_id=info%3Adoi%2F10.1249%2F01.MSS.0000089337.73244.9B&amp;rft_id=info%3Apmid%2F14523308&amp;rft.issue=10&amp;rft.jtitle=Med.+Sci.+Sports+Exerc&amp;rft.pages=1703-1709&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=35" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">He D, Xi B, Xue J, Huai P, Zhang M, Li J (2013). "Association between leisure time physical activity and metabolic syndrome: a meta-analysis of prospective cohort studies". <i>Endocrine</i> <b>46</b>: 231–240. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs12020-013-0110-0">10.1007/s12020-013-0110-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24287790">24287790</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Association+between+leisure+time+physical+activity+and+metabolic+syndrome%3A+a+meta-analysis+of+prospective+cohort+studies&amp;rft.au=He+D%2C+Xi+B%2C+Xue+J%2C+Huai+P%2C+Zhang+M%2C+Li+J&amp;rft.aulast=He+D%2C+Xi+B%2C+Xue+J%2C+Huai+P%2C+Zhang+M%2C+Li+J&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs12020-013-0110-0&amp;rft_id=info%3Apmid%2F24287790&amp;rft.jtitle=Endocrine&amp;rft.pages=231-240&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID23890470-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID23890470_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Xi B, He D, Zhang M, Xue J, Zhou D (2013). "Short sleep duration predicts risk of metabolic syndrome: A systematic review and meta-analysis". <i>Sleep Med Rev.</i> <b>18</b>: 293–297. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.smrv.2013.06.001">10.1016/j.smrv.2013.06.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23890470">23890470</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Short+sleep+duration+predicts+risk+of+metabolic+syndrome%3A+A+systematic+review+and+meta-analysis&amp;rft.aulast=Xi+B%2C+He+D%2C+Zhang+M%2C+Xue+J%2C+Zhou+D&amp;rft.au=Xi+B%2C+He+D%2C+Zhang+M%2C+Xue+J%2C+Zhou+D&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.smrv.2013.06.001&amp;rft_id=info%3Apmid%2F23890470&amp;rft.jtitle=Sleep+Med+Rev.&amp;rft.pages=293-297&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID24262678-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID24262678_15-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchell AJ, De Herdt A,Probst M, Scheewe TW, De Hert M. (2013). "Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables". <i>Psychol Med.</i> <b>21</b>: 1–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0033291713002778">10.1017/S0033291713002778</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24262678">24262678</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Metabolic+syndrome+and+metabolic+abnormalities+in+patients+with+major+depressive+disorder%3A+a+meta-analysis+of+prevalences+and+moderating+variables&amp;rft.aulast=Vancampfort+D%2C+Correll+CU%2C+Wampers+M%2C+Sienaert+P%2C+Mitchell+AJ%2C+De+Herdt+A%2CProbst+M%2C+Scheewe+TW%2C+De+Hert+M.&amp;rft.au=Vancampfort+D%2C+Correll+CU%2C+Wampers+M%2C+Sienaert+P%2C+Mitchell+AJ%2C+De+Herdt+A%2CProbst+M%2C+Scheewe+TW%2C+De+Hert+M.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0033291713002778&amp;rft_id=info%3Apmid%2F24262678&amp;rft.jtitle=Psychol+Med.&amp;rft.pages=1-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID23361837-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID23361837_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, Probst M, De Hert M. (2013). "Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators". <i>Am J Psychiatry.</i> <b>170</b> (3): 265–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1176%2Fappi.ajp.2012.12050620">10.1176/appi.ajp.2012.12050620</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23361837">23361837</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Metabolic+syndrome+and+metabolic+abnormalities+in+bipolar+disorder%3A+a+meta-analysis+of+prevalence+rates+and+moderators&amp;rft.aulast=Vancampfort+D%2C+Vansteelandt+K%2C+Correll+CU%2C+Mitchell+AJ%2C+De+Herdt+A%2C+Sienaert+P%2C+Probst+M%2C+De+Hert+M.&amp;rft.au=Vancampfort+D%2C+Vansteelandt+K%2C+Correll+CU%2C+Mitchell+AJ%2C+De+Herdt+A%2C+Sienaert+P%2C+Probst+M%2C+De+Hert+M.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.2012.12050620&amp;rft_id=info%3Apmid%2F23361837&amp;rft.issue=3&amp;rft.jtitle=Am+J+Psychiatry.&amp;rft.pages=265-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=170" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID24315622-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID24315622_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sun K, Ren M, Liu D, Wang C, Yang C, Yan L (2013). "Alcohol consumption and risk of metabolic syndrome: A meta-analysis of prospective studies.". <i>Clin Nutr.</i> <b>33</b>: 596–602. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.clnu.2013.10.003">10.1016/j.clnu.2013.10.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24315622">24315622</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Alcohol+consumption+and+risk+of+metabolic+syndrome%3A+A+meta-analysis+of+prospective+studies.&amp;rft.aulast=Sun+K%2C+Ren+M%2C+Liu+D%2C+Wang+C%2C+Yang+C%2C+Yan+L&amp;rft.au=Sun+K%2C+Ren+M%2C+Liu+D%2C+Wang+C%2C+Yang+C%2C+Yan+L&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clnu.2013.10.003&amp;rft_id=info%3Apmid%2F24315622&amp;rft.jtitle=Clin+Nutr.&amp;rft.pages=596-602&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ (2006). "A causal role for uric acid in fructose-induced metabolic syndrome". <i>Am J Phys Renal Phys</i> <b>290</b> (3): F625–F631. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1152%2Fajprenal.00140.2005">10.1152/ajprenal.00140.2005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16234313">16234313</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=A+causal+role+for+uric+acid+in+fructose-induced+metabolic+syndrome&amp;rft.aulast=Nakagawa+T%2C+Hu+H%2C+Zharikov+S%2C+Tuttle+KR%2C+Short+RA%2C+Glushakova+O%2C+Ouyang+X%2C+Feig+DI%2C+Block+ER%2C+Herrera-Acosta+J%2C+Patel+JM%2C+Johnson+RJ&amp;rft.au=Nakagawa+T%2C+Hu+H%2C+Zharikov+S%2C+Tuttle+KR%2C+Short+RA%2C+Glushakova+O%2C+Ouyang+X%2C+Feig+DI%2C+Block+ER%2C+Herrera-Acosta+J%2C+Patel+JM%2C+Johnson+RJ&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1152%2Fajprenal.00140.2005&amp;rft_id=info%3Apmid%2F16234313&amp;rft.issue=3&amp;rft.jtitle=Am+J+Phys+Renal+Phys&amp;rft.pages=F625-F631&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=290" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Hallfrisch J (1990). "Metabolic effects of dietary fructose". <i>FASEB J</i> <b>4</b> (9): 2652–2660. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2189777">2189777</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Metabolic+effects+of+dietary+fructose&amp;rft.au=Hallfrisch+J&amp;rft.aulast=Hallfrisch+J&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2189777&amp;rft.issue=9&amp;rft.jtitle=FASEB+J&amp;rft.pages=2652-2660&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ (1989). "Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch". <i>Am J Clin Nutr</i> <b>49</b> (5): 832–839. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2497634">2497634</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Blood+lipids%2C+lipoproteins%2C+apoproteins%2C+and+uric+acid+in+men+fed+diets+containing+fructose+or+high-amylose+cornstarch&amp;rft.aulast=Reiser+S%2C+Powell+AS%2C+Scholfield+DJ%2C+Panda+P%2C+Ellwood+KC%2C+Canary+JJ&amp;rft.au=Reiser+S%2C+Powell+AS%2C+Scholfield+DJ%2C+Panda+P%2C+Ellwood+KC%2C+Canary+JJ&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2497634&amp;rft.issue=5&amp;rft.jtitle=Am+J+Clin+Nutr&amp;rft.pages=832-839&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID22351884-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID22351884_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bremer, AA,; Mietus-Snyder, M,; Lustig, RH. (2012 Mar;). "Toward a unifying hypothesis of metabolic syndrome.". <i>Pediatrics.</i> <b>129</b> (3): 557–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1542%2Fpeds.2011-2912">10.1542/peds.2011-2912</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22351884">22351884</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Toward+a+unifying+hypothesis+of+metabolic+syndrome.&amp;rft.au=Bremer%2C+AA%2C&amp;rft.aufirst=AA%2C&amp;rft.aulast=Bremer&amp;rft.au=Lustig%2C+RH.&amp;rft.au=Mietus-Snyder%2C+M%2C&amp;rft.date=2012+Mar%3B&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2011-2912&amp;rft_id=info%3Apmid%2F22351884&amp;rft.issue=3&amp;rft.jtitle=Pediatrics.&amp;rft.pages=557-70.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=129" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="font-size:100%" class="error citation-comment">Check date values in: <code style="color:inherit; border:inherit; padding:inherit;">|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Gohill-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gohill_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gohill, BC; Rosenblum, LA; Coplan, JD; Kral, JG; (July 2001). "Hypothalamic-pituitary-adrenal axis function and the metabolic syndrome X of obesity". <i>CNS Spectr.</i> <b>6</b> (7): 581–6, 589. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15573024">15573024</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Hypothalamic-pituitary-adrenal+axis+function+and+the+metabolic+syndrome+X+of+obesity&amp;rft.aufirst=BC&amp;rft.au=Gohill%2C+BC&amp;rft.aulast=Gohill&amp;rft.date=July+2001&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15573024&amp;rft.issue=7&amp;rft.jtitle=CNS+Spectr.&amp;rft.pages=581-6%2C+589&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-tsigos-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-tsigos_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tsigos, C; Chrousos, GP; (October 2002). "Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress". <i>J Psychosom Res.</i> <b>53</b> (4): 865–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-3999%2802%2900429-4">10.1016/S0022-3999(02)00429-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12377295">12377295</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Hypothalamic-pituitary-adrenal+axis%2C+neuroendocrine+factors+and+stress&amp;rft.aufirst=C&amp;rft.aulast=Tsigos&amp;rft.au=Tsigos%2C+C&amp;rft.date=October+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-3999%2802%2900429-4&amp;rft_id=info%3Apmid%2F12377295&amp;rft.issue=4&amp;rft.jtitle=J+Psychosom+Res.&amp;rft.pages=865-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-rosmond-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-rosmond_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosmond, R; Björntorp, P; (February 2000). "The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke". <i>Journal of Internal Medicine</i> <b>247</b> (2): 188–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2796.2000.00603.x">10.1046/j.1365-2796.2000.00603.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10692081">10692081</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=The+hypothalamic-pituitary-adrenal+axis+activity+as+a+predictor+of+cardiovascular+disease%2C+type+2+diabetes+and+stroke&amp;rft.aufirst=R&amp;rft.aulast=Rosmond&amp;rft.au=Rosmond%2C+R&amp;rft.date=February+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2796.2000.00603.x&amp;rft_id=info%3Apmid%2F10692081&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Internal+Medicine&amp;rft.pages=188-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=247" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-brunner-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-brunner_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brunner, EJ; Hemingway, H; Walker, BR; Page, M; Clarke, P; Juneja, M; Shipley, MJ; Kumari, M; Andrew, R; Seckl, JR; Papadopoulos, A; Checkley, S; Rumley, A; Lowe, GD; Stansfeld, SA; Marmot, MG; (November 2002). "Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study". <i>Circulation.</i> <b>106</b> (21): 2634–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12438290">12438290</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Adrenocortical%2C+autonomic%2C+and+inflammatory+causes+of+the+metabolic+syndrome%3A+nested+case-control+study&amp;rft.au=Brunner%2C+EJ&amp;rft.aufirst=EJ&amp;rft.aulast=Brunner&amp;rft.date=November+2002&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12438290&amp;rft.issue=21&amp;rft.jtitle=Circulation.&amp;rft.pages=2634-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-isbn0-07-147692-X-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn0-07-147692-X_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_26-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_26-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_26-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-isbn0-07-147692-X_26-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Fauci, Anthony S. (2008). <i>Harrison's principles of internal medicine</i>. McGraw-Hill Medical. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-07-147692-X" title="Special:BookSources/0-07-147692-X">0-07-147692-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.au=Fauci%2C+Anthony+S.&amp;rft.aulast=Fauci%2C+Anthony+S.&amp;rft.btitle=Harrison%27s+principles+of+internal+medicine&amp;rft.date=2008&amp;rft.genre=book&amp;rft.isbn=0-07-147692-X&amp;rft.pub=McGraw-Hill+Medical&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID22895669-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID22895669_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Goldberg RB, Mather K (2012). "Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program". <i><a href="/wiki/Arteriosclerosis,_Thrombosis,_and_Vascular_Biology" title="Arteriosclerosis, Thrombosis, and Vascular Biology">Arteriosclerosis, Thrombosis, and Vascular Biology</a></i> <b>32</b> (9): 2077–2090. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2FATVBAHA.111.241893">10.1161/ATVBAHA.111.241893</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22895669">22895669</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Targeting+the+Consequences+of+the+Metabolic+Syndrome+in+the+Diabetes+Prevention+Program&amp;rft.au=Goldberg+RB%2C+Mather+K&amp;rft.aulast=Goldberg+RB%2C+Mather+K&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2FATVBAHA.111.241893&amp;rft_id=info%3Apmid%2F22895669&amp;rft.issue=9&amp;rft.jtitle=Arteriosclerosis%2C+Thrombosis%2C+and+Vascular+Biology&amp;rft.pages=2077-2090&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17495599-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17495599_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lara-Castro C, Fu Y, Chung BH, Garvey WT (June 2007). <a rel="nofollow" class="external text" href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00041433-200706000-00007">"Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease"</a>. <i><a href="/w/index.php?title=Current_Opinion_in_Lipidology&amp;action=edit&amp;redlink=1" class="new" title="Current Opinion in Lipidology (page does not exist)">Current Opinion in Lipidology</a></i> <b>18</b> (3): 263–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FMOL.0b013e32814a645f">10.1097/MOL.0b013e32814a645f</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17495599">17495599</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Adiponectin+and+the+metabolic+syndrome%3A+mechanisms+mediating+risk+for+metabolic+and+cardiovascular+disease&amp;rft.au=Lara-Castro+C%2C+Fu+Y%2C+Chung+BH%2C+Garvey+WT&amp;rft.aulast=Lara-Castro+C%2C+Fu+Y%2C+Chung+BH%2C+Garvey+WT&amp;rft.date=June+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fmeta.wkhealth.com%2Fpt%2Fpt-core%2Ftemplate-journal%2Flwwgateway%2Fmedia%2Flandingpage.htm%3Fan%3D00041433-200706000-00007&amp;rft_id=info%3Adoi%2F10.1097%2FMOL.0b013e32814a645f&amp;rft_id=info%3Apmid%2F17495599&amp;rft.issue=3&amp;rft.jtitle=Current+Opinion+in+Lipidology&amp;rft.pages=263-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19258676-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19258676_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Renaldi O, Pramono B, Sinorita H, Purnomo LB, Asdie RH, Asdie AH (January 2009). "Hypoadiponectinemia: a risk factor for metabolic syndrome". <i><a href="/w/index.php?title=Acta_Med_Indones&amp;action=edit&amp;redlink=1" class="new" title="Acta Med Indones (page does not exist)">Acta Med Indones</a></i> <b>41</b> (1): 20–4. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19258676">19258676</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Hypoadiponectinemia%3A+a+risk+factor+for+metabolic+syndrome&amp;rft.aulast=Renaldi+O%2C+Pramono+B%2C+Sinorita+H%2C+Purnomo+LB%2C+Asdie+RH%2C+Asdie+AH&amp;rft.au=Renaldi+O%2C+Pramono+B%2C+Sinorita+H%2C+Purnomo+LB%2C+Asdie+RH%2C+Asdie+AH&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19258676&amp;rft.issue=1&amp;rft.jtitle=Acta+Med+Indones&amp;rft.pages=20-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">John, A. P.; Koloth, R.; Dragovic, M.; Lim, S. C. (2009). "Prevalence of metabolic syndrome among Australians with severe mental illness". <i>The Medical journal of Australia</i> <b>190</b> (4): 176–179. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19220180">19220180</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Prevalence+of+metabolic+syndrome+among+Australians+with+severe+mental+illness&amp;rft.au=Dragovic%2C+M.&amp;rft.aufirst=A.+P.&amp;rft.au=John%2C+A.+P.&amp;rft.au=Koloth%2C+R.&amp;rft.aulast=John&amp;rft.au=Lim%2C+S.+C.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19220180&amp;rft.issue=4&amp;rft.jtitle=The+Medical+journal+of+Australia&amp;rft.pages=176-179&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=190" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19220180&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text">Narasimhan M, Raynor JD. <a rel="nofollow" class="external text" href="http://dbt.consultantlive.com/health-care-reform/content/article/1145628/1555034">Evidence-based perspective on metabolic syndrome and use of antipsychotics</a>. Drug Benefit Trends. 2010;22:77-88.DEAD LINK</span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Hotamisligil GS. (June 1999). "The Role of TNF-alpha and TNF receptors in Obesity and Insulin Resistance". <i><a href="/wiki/Journal_of_Internal_Medicine" title="Journal of Internal Medicine">Journal of Internal Medicine</a></i> <b>245</b> (6): 621–625. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2796.1999.00490.x">10.1046/j.1365-2796.1999.00490.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10395191">10395191</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=The+Role+of+TNF-alpha+and+TNF+receptors+in+Obesity+and+Insulin+Resistance&amp;rft.au=Hotamisligil+GS.&amp;rft.aulast=Hotamisligil+GS.&amp;rft.date=June+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2796.1999.00490.x&amp;rft_id=info%3Apmid%2F10395191&amp;rft.issue=6&amp;rft.jtitle=Journal+of+Internal+Medicine&amp;rft.pages=621-625&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H. (1 June 2004). <a rel="nofollow" class="external text" href="http://www.ebmonline.org/cgi/content/full/229/6/486">"Role of Fatty Acid Composition in the Development of Metabolic Disorders in Sucrose-Induced Obese Rats"</a>. <i><a href="/wiki/Exp_Biol_Med" title="Exp Biol Med" class="mw-redirect">Exp Biol Med</a></i> <b>229</b> (6): 486–493. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15169967">15169967</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Role+of+Fatty+Acid+Composition+in+the+Development+of+Metabolic+Disorders+in+Sucrose-Induced+Obese+Rats&amp;rft.au=Fukuchi+S%2C+Hamaguchi+K%2C+Seike+M%2C+Himeno+K%2C+Sakata+T%2C+Yoshimatsu+H.&amp;rft.aulast=Fukuchi+S%2C+Hamaguchi+K%2C+Seike+M%2C+Himeno+K%2C+Sakata+T%2C+Yoshimatsu+H.&amp;rft.date=1+June+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ebmonline.org%2Fcgi%2Fcontent%2Ffull%2F229%2F6%2F486&amp;rft_id=info%3Apmid%2F15169967&amp;rft.issue=6&amp;rft.jtitle=Exp+Biol+Med&amp;rft.pages=486-493&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=229" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text">Whitney, Ellie and Ralfes, R. Sharon. 2011. <i>Understanding Nutrition</i>. <a href="/wiki/Wadsworth_Cengage_Learning" title="Wadsworth Cengage Learning" class="mw-redirect">Wadsworth Cengage Learning</a>: Belmont, CA</span></li>
<li id="cite_note-Farooqui-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Farooqui_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Farooqui, AA; Farooqui T; Panza F; Frisardi V. (2012). "Metabolic syndrome as a risk factor for neurological disorders". <i><a href="/wiki/Cell_Mol_Life_Sci." title="Cell Mol Life Sci." class="mw-redirect">Cell Mol Life Sci.</a></i> <b>69</b> (5): 741–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00018-011-0840-1">10.1007/s00018-011-0840-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21997383">21997383</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Metabolic+syndrome+as+a+risk+factor+for+neurological+disorders&amp;rft.au=Farooqui%2C+AA&amp;rft.au=Farooqui+T&amp;rft.aufirst=AA&amp;rft.au=Frisardi+V.&amp;rft.aulast=Farooqui&amp;rft.au=Panza+F&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00018-011-0840-1&amp;rft_id=info%3Apmid%2F21997383&amp;rft.issue=5&amp;rft.jtitle=Cell+Mol+Life+Sci.&amp;rft.pages=741-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID20870782-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMID20870782_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMID20870782_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Alberti, KG,; Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. (2009). "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.". <i>Circulation</i> <b>120</b> (16): 1640–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2FCIRCULATIONAHA.109.192644">10.1161/CIRCULATIONAHA.109.192644</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19805654">19805654</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Harmonizing+the+metabolic+syndrome%3A+a+joint+interim+statement+of+the+International+Diabetes+Federation+Task+Force+on+Epidemiology+and+Prevention%3B+National+Heart%2C+Lung%2C+and%0ABlood+Institute%3B+American+Heart+Association%3B+World+Heart+Federation%3B+International+Atherosclerosis+Society%3B+and+International+Association+for+the+Study+of+Obesity.&amp;rft.au=Alberti%2C+KG%2C&amp;rft.aufirst=KG%2C&amp;rft.aulast=Alberti&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.109.192644&amp;rft_id=info%3Apmid%2F19805654&amp;rft.issue=16&amp;rft.jtitle=Circulation&amp;rft.pages=1640-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-idf.org-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-idf.org_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-idf.org_37-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">(IDF) consensus <a rel="nofollow" class="external text" href="http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf">PDF</a></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation web">Alberti, KGMM; Zimmet (1999). <a rel="nofollow" class="external text" href="http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf,">"Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications"</a> <span style="font-size:85%;">(PDF)</span>. World Health Organization. pp.&#160;32–33<span class="reference-accessdate">. Retrieved <span class="nowrap">25 March</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.au=Alberti%2C+KGMM&amp;rft.aufirst=KGMM&amp;rft.aulast=Alberti&amp;rft.au=Zimmet&amp;rft.btitle=Definition%2C+Diagnosis%2C+and+Classification+of+Diabetes+Mellitus+and+its+Complications&amp;rft.date=1999&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwhqlibdoc.who.int%2Fhq%2F1999%2Fwho_ncd_ncs_99.2.pdf%2C&amp;rft.pages=32-33&amp;rft.pub=World+Health+Organization&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (May 2001). "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)". <i>JAMA: the Journal of the American Medical Association</i> <b>285</b> (19): 2486–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.285.19.2486">10.1001/jama.285.19.2486</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11368702">11368702</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Executive+Summary+of+the+Third+Report+of+the+National+Cholesterol+Education+Program+%28NCEP%29+Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults+%28Adult+Treatment+Panel+III%29&amp;rft.au=Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults&amp;rft.aulast=Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults&amp;rft.date=May+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.285.19.2486&amp;rft_id=info%3Apmid%2F11368702&amp;rft.issue=19&amp;rft.jtitle=JAMA%3A+the+Journal+of+the+American+Medical+Association&amp;rft.pages=2486-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=285" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Grundy-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Grundy_40-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/reprint/109/3/433.pdf">Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant D, for the Conference Participants. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.</a> Circulation. 2004;109:433-438.</span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation journal">Grundy SM, Cleeman JI, Daniels SR et al. (October 2005). "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement". <i>Circulation</i> <b>112</b> (17): 2735–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2FCIRCULATIONAHA.105.169404">10.1161/CIRCULATIONAHA.105.169404</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16157765">16157765</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Diagnosis+and+management+of+the+metabolic+syndrome%3A+an+American+Heart+Association%2FNational+Heart%2C+Lung%2C+and+Blood+Institute+Scientific+Statement&amp;rft.au=Grundy+SM%2C+Cleeman+JI%2C+Daniels+SR&amp;rft.aulast=Grundy+SM%2C+Cleeman+JI%2C+Daniels+SR&amp;rft.date=October+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.105.169404&amp;rft_id=info%3Apmid%2F16157765&amp;rft.issue=17&amp;rft.jtitle=Circulation&amp;rft.pages=2735-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid19271113-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19271113_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K (March 2009). "High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population". <i><a href="/w/index.php?title=J._Gastroenterol.&amp;action=edit&amp;redlink=1" class="new" title="J. Gastroenterol. (page does not exist)">J. Gastroenterol.</a></i> <b>44</b> (4): 313–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00535-009-0002-5">10.1007/s00535-009-0002-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19271113">19271113</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=High-sensitivity+C-reactive+protein+as+a+serum+predictor+of+nonalcoholic+fatty+liver+disease+based+on+the+Akaike+Information+Criterion+scoring+system+in+the+general+Japanese+population&amp;rft.au=Kogiso+T%2C+Moriyoshi+Y%2C+Shimizu+S%2C+Nagahara+H%2C+Shiratori+K&amp;rft.aulast=Kogiso+T%2C+Moriyoshi+Y%2C+Shimizu+S%2C+Nagahara+H%2C+Shiratori+K&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00535-009-0002-5&amp;rft_id=info%3Apmid%2F19271113&amp;rft.issue=4&amp;rft.jtitle=J.+Gastroenterol.&amp;rft.pages=313-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text">Quilon A III, Brent L. <a rel="nofollow" class="external text" href="http://www.musculoskeletalnetwork.com/display/article/1145622/1579185">The primary care physician's guide to inflammatory arthritis: diagnosis</a>. J Musculoskel Med. 2010;27:223-231.</span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation journal">Lakka TA, Laaksonen DE (2007). "Physical activity in prevention and treatment of the metabolic syndrome". <i>Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme</i> <b>32</b> (1): 76–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1139%2Fh06-113">10.1139/h06-113</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17332786">17332786</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Physical+activity+in+prevention+and+treatment+of+the+metabolic+syndrome&amp;rft.au=Lakka+TA%2C+Laaksonen+DE&amp;rft.aulast=Lakka+TA%2C+Laaksonen+DE&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1139%2Fh06-113&amp;rft_id=info%3Apmid%2F17332786&amp;rft.issue=1&amp;rft.jtitle=Applied+physiology%2C+nutrition%2C+and+metabolism+%3D+Physiologie+appliqu%C3%A9e%2C+nutrition+et+m%C3%A9tabolisme&amp;rft.pages=76-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><span class="citation journal">Feldeisen SE, Tucker KL (2007). "Nutritional strategies in the prevention and treatment of metabolic syndrome". <i>Appl Physiol Nutr Metab</i> <b>32</b> (1): 46–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1139%2Fh06-101">10.1139/h06-101</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17332784">17332784</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Nutritional+strategies+in+the+prevention+and+treatment+of+metabolic+syndrome&amp;rft.au=Feldeisen+SE%2C+Tucker+KL&amp;rft.aulast=Feldeisen+SE%2C+Tucker+KL&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1139%2Fh06-101&amp;rft_id=info%3Apmid%2F17332784&amp;rft.issue=1&amp;rft.jtitle=Appl+Physiol+Nutr+Metab&amp;rft.pages=46-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><span class="citation journal">James PT, Rigby N, Leach R (2004). "The obesity epidemic, metabolic syndrome and future prevention strategies". <i>Eur J Cardiovasc Prev Rehabil</i> <b>11</b> (1): 3–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.hjr.0000114707.27531.48">10.1097/01.hjr.0000114707.27531.48</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15167200">15167200</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=The+obesity+epidemic%2C+metabolic+syndrome+and+future+prevention+strategies&amp;rft.au=James+PT%2C+Rigby+N%2C+Leach+R&amp;rft.aulast=James+PT%2C+Rigby+N%2C+Leach+R&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.hjr.0000114707.27531.48&amp;rft_id=info%3Apmid%2F15167200&amp;rft.issue=1&amp;rft.jtitle=Eur+J+Cardiovasc+Prev+Rehabil&amp;rft.pages=3-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><span class="citation journal">Elwood, PC; Pickering JE; Fehily AM (2007). <a rel="nofollow" class="external text" href="http://jech.bmj.com/cgi/content/abstract/61/8/695">"Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study"</a>. <i>J Epidemiol Community Health</i> <b>61</b> (8): 695–698. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjech.2006.053157">10.1136/jech.2006.053157</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2652996">2652996</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17630368">17630368</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Milk+and+dairy+consumption%2C+diabetes+and+the+metabolic+syndrome%3A+the+Caerphilly+prospective+study&amp;rft.au=Elwood%2C+PC&amp;rft.au=Fehily+AM&amp;rft.aufirst=PC&amp;rft.aulast=Elwood&amp;rft.au=Pickering+JE&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjech.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F61%2F8%2F695&amp;rft_id=info%3Adoi%2F10.1136%2Fjech.2006.053157&amp;rft_id=info%3Apmc%2F2652996&amp;rft_id=info%3Apmid%2F17630368&amp;rft.issue=8&amp;rft.jtitle=J+Epidemiol+Community+Health&amp;rft.pages=695-698&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Snijder MB, van der Heijden AA, van Dam RM et al. (2007). "Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study". <i>Am. J. Clin. Nutr.</i> <b>85</b> (4): 989–95. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17413097">17413097</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Is+higher+dairy+consumption+associated+with+lower+body+weight+and+fewer+metabolic+disturbances%3F+The+Hoorn+Study&amp;rft.aulast=Snijder+MB%2C+van+der+Heijden+AA%2C+van+Dam+RM&amp;rft.au=Snijder+MB%2C+van+der+Heijden+AA%2C+van+Dam+RM&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F17413097&amp;rft.issue=4&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.pages=989-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation journal">Garvey, William Timothy (September 2013). "Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management". <i>Expert Opinion on Drug Safety</i> <b>12</b> (5): 741–756. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1517%2F14740338.2013.806481">10.1517/14740338.2013.806481</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Phentermine+and+topiramate+extended-release%3A+a+new+treatment+for+obesity+and+its+role+in+a+complications-centric+approach+to+obesity+medical+management&amp;rft.aufirst=William+Timothy&amp;rft.au=Garvey%2C+William+Timothy&amp;rft.aulast=Garvey&amp;rft.date=September+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1517%2F14740338.2013.806481&amp;rft.issue=5&amp;rft.jtitle=Expert+Opinion+on+Drug+Safety&amp;rft.pages=741-756&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-n.26m2005-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-n.26m2005_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Volek JS, Feinman RD (2005). <a rel="nofollow" class="external text" href="http://www.nutritionandmetabolism.com/content/2/1/31">"Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction"</a>. <i>Nutr Metab (Lond)</i> <b>2</b> (1): 31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1743-7075-2-31">10.1186/1743-7075-2-31</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1323303">1323303</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16288655">16288655</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Carbohydrate+restriction+improves+the+features+of+Metabolic+Syndrome.+Metabolic+Syndrome+may+be+defined+by+the+response+to+carbohydrate+restriction&amp;rft.aulast=Volek+JS%2C+Feinman+RD&amp;rft.au=Volek+JS%2C+Feinman+RD&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nutritionandmetabolism.com%2Fcontent%2F2%2F1%2F31&amp;rft_id=info%3Adoi%2F10.1186%2F1743-7075-2-31&amp;rft_id=info%3Apmc%2F1323303&amp;rft_id=info%3Apmid%2F16288655&amp;rft.issue=1&amp;rft.jtitle=Nutr+Metab+%28Lond%29&amp;rft.pages=31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation news">Liscinsky, Morgan (2011-10-07). <a rel="nofollow" class="external text" href="http://www.fda.gov/newsevents/newsroom/pressannouncements/2011/ucm274748.htm">"FDA Approves Combination Therapy Juvisync"</a>. <i>FDA News Release</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2013-12-11</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=FDA+Approves+Combination+Therapy+Juvisync&amp;rft.aufirst=Morgan&amp;rft.aulast=Liscinsky&amp;rft.au=Liscinsky%2C+Morgan&amp;rft.date=2011-10-07&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fnewsevents%2Fnewsroom%2Fpressannouncements%2F2011%2Fucm274748.htm&amp;rft.jtitle=FDA+News+Release&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><span class="citation web">U.S. Food and Drug Administration. <a rel="nofollow" class="external text" href="http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050794.htm">"Drugs to be Discontinued"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2013-12-11</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.aulast=U.S.+Food+and+Drug+Administration&amp;rft.au=U.S.+Food+and+Drug+Administration&amp;rft.btitle=Drugs+to+be+Discontinued&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrugsafety%2Fdrugshortages%2Fucm050794.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text">Alberti, George, Paul Zimmet, and Johnathan Shaw. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Publication. Ed. Scott M. Grundy. Brussels, Belgium: International Diabetes Federation, 2006. Web. 29 Nov. 2012. &lt;<a rel="nofollow" class="external free" href="http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf">http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf</a>&gt;.</span></li>
<li id="cite_note-Ford_ES-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ford_ES_54-0">^</a></b></span> <span class="reference-text">Ford ES. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the U.S. J Diabetes. 2010;2:180-193.</span></li>
<li id="cite_note-Ford_ES_et_al-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ford_ES_et_al_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ford_ES_et_al_55-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Ford ES et al. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-2449.</span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text">Mozumdar A and Liguori G. Persistent increase in prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011; 34:216-219.</span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal">Joslin EP (1921). "The prevention of diabetes mellitus". <i>JAMA</i> <b>76</b>: 79–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.1921.02630020001001">10.1001/jama.1921.02630020001001</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=The+prevention+of+diabetes+mellitus&amp;rft.au=Joslin+EP&amp;rft.aulast=Joslin+EP&amp;rft.date=1921&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1921.02630020001001&amp;rft.jtitle=JAMA&amp;rft.pages=79-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text">Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] (German). <i>Zentralbl Inn Med</i> 1923;44: 105-27.</span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Vague J (1947). "La diffférenciacion sexuelle, facteur déterminant des formes de l'obésité". <i>Presse Med</i> <b>30</b>: 339–40.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=La+difff%C3%A9renciacion+sexuelle%2C+facteur+d%C3%A9terminant+des+formes+de+l%27ob%C3%A9sit%C3%A9&amp;rft.aulast=Vague+J&amp;rft.au=Vague+J&amp;rft.date=1947&amp;rft.genre=article&amp;rft.jtitle=Presse+Med&amp;rft.pages=339-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><span class="citation journal">Avogadro A, Crepaldi G, Enzi G, Tiengo A (1967). "Associazione di iperlipidemia, diabete mellito e obesità di medio grado". <i>Acta Diabetol Lat</i> <b>4</b>: 572–590.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Associazione+di+iperlipidemia%2C+diabete+mellito+e+obesit%C3%A0+di+medio+grado&amp;rft.au=Avogadro+A%2C+Crepaldi+G%2C+Enzi+G%2C+Tiengo+A&amp;rft.aulast=Avogadro+A%2C+Crepaldi+G%2C+Enzi+G%2C+Tiengo+A&amp;rft.date=1967&amp;rft.genre=article&amp;rft.jtitle=Acta+Diabetol+Lat&amp;rft.pages=572-590&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Haller H (April 1977). "Epidermiology and associated risk factors of hyperlipoproteinemia". <i>Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete</i> <b>32</b> (8): 124–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/883354">883354</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Epidermiology+and+associated+risk+factors+of+hyperlipoproteinemia&amp;rft.au=Haller+H&amp;rft.aulast=Haller+H&amp;rft.date=April+1977&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F883354&amp;rft.issue=8&amp;rft.jtitle=Zeitschrift+fur+die+gesamte+innere+Medizin+und+ihre+Grenzgebiete&amp;rft.pages=124-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Singer P (May 1977). "Diagnosis of primary hyperlipoproteinemias". <i>Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete</i> <b>32</b> (9): 129–33 concl. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/906591">906591</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Diagnosis+of+primary+hyperlipoproteinemias&amp;rft.aulast=Singer+P&amp;rft.au=Singer+P&amp;rft.date=May+1977&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F906591&amp;rft.issue=9&amp;rft.jtitle=Zeitschrift+fur+die+gesamte+innere+Medizin+und+ihre+Grenzgebiete&amp;rft.pages=129-33+concl&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation journal">Phillips GB (July 1978). "Sex hormones, risk factors and cardiovascular disease". <i>The American Journal of Medicine</i> <b>65</b> (1): 7–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0002-9343%2878%2990685-X">10.1016/0002-9343(78)90685-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/356599">356599</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Sex+hormones%2C+risk+factors+and+cardiovascular+disease&amp;rft.aulast=Phillips+GB&amp;rft.au=Phillips+GB&amp;rft.date=July+1978&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0002-9343%2878%2990685-X&amp;rft_id=info%3Apmid%2F356599&amp;rft.issue=1&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.pages=7-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Phillips GB (April 1977). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC430867">"Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i> <b>74</b> (4): 1729–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.74.4.1729">10.1073/pnas.74.4.1729</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC430867">430867</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/193114">193114</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Relationship+between+serum+sex+hormones+and+glucose%2C+insulin+and+lipid+abnormalities+in+men+with+myocardial+infarction&amp;rft.aulast=Phillips+GB&amp;rft.au=Phillips+GB&amp;rft.date=April+1977&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC430867&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.74.4.1729&amp;rft_id=info%3Apmc%2F430867&amp;rft_id=info%3Apmid%2F193114&amp;rft.issue=4&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.pages=1729-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=74" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation journal">Reaven (1988). "Role of <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> in human disease". <i>Diabetes</i> <b>37</b> (12): 1595–607. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdiabetes.37.12.1595">10.2337/diabetes.37.12.1595</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3056758">3056758</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Role+of+insulin+resistance+in+human+disease&amp;rft.aulast=Reaven&amp;rft.au=Reaven&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdiabetes.37.12.1595&amp;rft_id=info%3Apmid%2F3056758&amp;rft.issue=12&amp;rft.jtitle=Diabetes&amp;rft.pages=1595-607&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation journal">Kahn R, Buse J, Ferrannini E, Stern M (2005). "The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes". <i>Diabetes Care</i> <b>28</b> (9): 2289–2304. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdiacare.28.9.2289">10.2337/diacare.28.9.2289</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16123508">16123508</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=The+metabolic+syndrome%3A+time+for+a+critical+appraisal.+Joint+statement+from+the+American+Diabetes+Association+and+the+European+Association+for+the+Study+of+Diabetes&amp;rft.au=Kahn+R%2C+Buse+J%2C+Ferrannini+E%2C+Stern+M&amp;rft.aulast=Kahn+R%2C+Buse+J%2C+Ferrannini+E%2C+Stern+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.28.9.2289&amp;rft_id=info%3Apmid%2F16123508&amp;rft.issue=9&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=2289-2304&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Richard Kahn (2008). "Metabolic syndrome—what is the clinical usefulness?". <i>Lancet</i> <b>371</b> (9628): 1892–1893. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2808%2960731-X">10.1016/S0140-6736(08)60731-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetabolic+syndrome&amp;rft.atitle=Metabolic+syndrome%E2%80%94what+is+the+clinical+usefulness%3F&amp;rft.aulast=Richard+Kahn&amp;rft.au=Richard+Kahn&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2808%2960731-X&amp;rft.issue=9628&amp;rft.jtitle=Lancet&amp;rft.pages=1892-1893&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=371" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit&amp;section=26" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://ppap21.stanford.edu/do/serve?objId=PA447159&amp;objCls=Disease">Metabolic Syndrome X</a> at the Stanford University Pharmacogenomic Knowledge Base</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://id.ndl.go.jp/auth/ndlna/01072616">01072616</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1239
CPU time usage: 0.493 seconds
Real time usage: 0.574 seconds
Preprocessor visited node count: 4030/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 134162/2097152 bytes
Template argument size: 1791/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 4/500
Lua time usage: 0.196/10.000 seconds
Lua memory usage: 3.91 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  476.473      1 - -total
 54.33%  258.877      1 - Template:Reflist
 32.56%  155.149     51 - Template:Cite_journal
 16.41%   78.168      1 - Template:Infobox_disease
 14.19%   67.597      1 - Template:Infobox
 10.12%   48.231      3 - Template:Citation_needed
  8.53%   40.624      3 - Template:Fix
  7.60%   36.213      6 - Template:Category_handler
  5.30%   25.237      1 - Template:Authority_control
  3.69%   17.568      1 - Template:Comma_separated_entries
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:54439-0!*!0!!en!4!* and timestamp 20150711051058 and revision id 670782655
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Metabolic_syndrome&amp;oldid=670782655">https://en.wikipedia.org/w/index.php?title=Metabolic_syndrome&amp;oldid=670782655</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Diabetes" title="Category:Diabetes">Diabetes</a></li><li><a href="/wiki/Category:Endocrine_diseases" title="Category:Endocrine diseases">Endocrine diseases</a></li><li><a href="/wiki/Category:Medical_conditions_related_to_obesity" title="Category:Medical conditions related to obesity">Medical conditions related to obesity</a></li><li><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_February_2015" title="Category:Articles with unsourced statements from February 2015">Articles with unsourced statements from February 2015</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_May_2014" title="Category:Articles with unsourced statements from May 2014">Articles with unsourced statements from May 2014</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_May_2012" title="Category:Articles with unsourced statements from May 2012">Articles with unsourced statements from May 2012</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metabolic+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metabolic+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Metabolic_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Metabolic_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Metabolic_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Metabolic_syndrome&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Metabolic_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Metabolic_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Metabolic_syndrome&amp;oldid=670782655" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Metabolic_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q657193" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Metabolic_syndrome&amp;id=670782655" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Metabolic+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Metabolic+syndrome&amp;oldid=670782655&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Metabolic_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A3%D9%8A%D8%B6%D9%8A%D8%A9" title="متلازمة أيضية – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D0%B0%D0%B1%D0%BE%D0%BB%D0%B8%D1%82%D0%B5%D0%BD_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Метаболитен синдром – Bulgarian" lang="bg" hreflang="bg">Български</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/S%C3%ADndrome_metab%C3%B2lica" title="Síndrome metabòlica – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Metabolick%C3%BD_syndrom" title="Metabolický syndrom – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Metabolisches_Syndrom" title="Metabolisches Syndrom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/S%C3%ADndrome_metab%C3%B3lico" title="Síndrome metabólico – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%D9%85%D8%AA%D8%A7%D8%A8%D9%88%D9%84%DB%8C%DA%A9" title="سندرم متابولیک – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Syndrome_m%C3%A9tabolique" title="Syndrome métabolique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%8C%80%EC%82%AC_%EC%A6%9D%ED%9B%84%EA%B5%B0" title="대사 증후군 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%89%E0%A4%AA%E0%A4%BE%E0%A4%AA%E0%A4%9A%E0%A4%AF_%E0%A4%B8%E0%A4%82%E0%A4%B2%E0%A4%95%E0%A5%8D%E0%A4%B7%E0%A4%A3" title="उपापचय संलक्षण – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Metaboli%C4%8Dki_sindrom" title="Metabolički sindrom – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Sindrom_resistansi_insulin" title="Sindrom resistansi insulin – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//it.wikipedia.org/wiki/Sindrome_metabolica" title="Sindrome metabolica – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%94%D7%AA%D7%A1%D7%9E%D7%95%D7%A0%D7%AA_%D7%94%D7%9E%D7%98%D7%91%D7%95%D7%9C%D7%99%D7%AA" title="התסמונת המטבולית – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-mr"><a href="//mr.wikipedia.org/wiki/%E0%A4%AE%E0%A5%87%E0%A4%9F%E0%A5%85%E0%A4%AC%E0%A5%8B%E0%A4%B2%E0%A4%BF%E0%A4%95_%E0%A4%B8%E0%A4%BF%E0%A4%A8%E0%A5%8D%E0%A4%A1%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%AE" title="मेटॅबोलिक सिन्ड्रोम – Marathi" lang="mr" hreflang="mr">मराठी</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Metabool_syndroom" title="Metabool syndroom – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%A1%E3%82%BF%E3%83%9C%E3%83%AA%E3%83%83%E3%82%AF%E3%82%B7%E3%83%B3%E3%83%89%E3%83%AD%E3%83%BC%E3%83%A0" title="メタボリックシンドローム – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_metaboliczny" title="Zespół metaboliczny – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/S%C3%ADndrome_metab%C3%B3lica" title="Síndrome metabólica – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D0%B0%D0%B1%D0%BE%D0%BB%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Метаболический синдром – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Metabolic_syndrome" title="Metabolic syndrome – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Presnovni_sindrom" title="Presnovni sindrom – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Metabolinen_oireyhtym%C3%A4" title="Metabolinen oireyhtymä – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Metabolt_syndrom" title="Metabolt syndrom – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E4%BB%A3%E8%AC%9D%E7%97%87%E5%80%99%E7%BE%A4" title="代謝症候群 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q657193#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 10 July 2015, at 05:09.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Metabolic_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":109,"wgHostname":"mw1174"});
}</script>
	</body>
</html>
